UNITAID An innovative mechanism for scaling up access to medicines and diagnostics for HIV/AIDS,...
-
Upload
jamari-penson -
Category
Documents
-
view
216 -
download
1
Transcript of UNITAID An innovative mechanism for scaling up access to medicines and diagnostics for HIV/AIDS,...
UNITAID An innovative mechanism for scaling up access to medicines and diagnostics for HIV/AIDS, tuberculosis and malaria
ROMANIAN DEVELOPMENT CAMP
Second Edition, Venus – Romania September 16-19,2009
Pascale Daou, Donor Relations Officer, UNITAID
Building the way
2000 – The MDG's
“Finding new flows of development finance is crucial if the world is to meet its ambitious series of anti-poverty goals by the target date of 2015.”
UN Secretary-General Ban Ki-Moon
2002 - Monterrey consensus on financing for
development
2004 - The Global Action against Hunger and Poverty
2005 - New York Declaration on Innovative Sources of
Financing for Development
2006 - The Leading Group on Innovative Financing
Building the way
Official signature of the five founding countries when UNITAID was launched, on 19 September 2006, at the United Nations General Assembly, New York
Five founding countries (September 2006)
Medicines are in the North, patients in the South
Less developed countries represent:
84% of the world population
Less than 11% of the global health expenditure
More than 93% of the disease burden globally
A global challenge for Health…
UNITAID’s mission is to contribute to scale up access to treatment for HIV/AIDS, malaria and tuberculosis for the people in developing countries by leveraging price reductions of quality drugs and diagnostics, which currently are unaffordable for most developing countries, and to accelerate the pace at which they are made available.
UNITAID mission
•UNITAID is an innovative funding mechanism, hosted by WHO
• Facing a global state of emergency, UNITAID contributes to bring solutions
UNITAID added value
From 5 founding countries (2006): Brazil, Chile, France, Norway, UK
Now (2009): supported by 29 countries and the Gates foundation
UNITAID membership
UNITAID: What is Innovative?
Innovative funding : How?
Funds in UNITAID :
- Innovative
- Additional sources
- Sustainable and predictable
UNITAID now
How the air tax works
Applied to all airlines departing from countries that impose it
Paid by all passengers when purchasing their ticket as an addition to existing airport tax
Airlines are responsible for declaring and collecting the levy
Passengers in transit are exempt (no administrative burden for airport in participating countries)
Solidarity levy respects countries' tax sovereignty
The decision making process
Political decision on the principle
Interministerial discussion
Collection of revenue
Consultation with other stakeholders
Entry into force of the law
Adoption of the law
A flexible 'air tax' approach
Furthermore… no economic impact on air traffic
Zero economic impact
One dollar makes little difference to a passenger. To a child with malaria, it can mean the difference between life and death
Funds collected
US$'000s
Funds collected in 2008 349,059
Funds collected in 2006-2007 368,889
TOTAL 717,948
Over US$ 900 Million committed funds
HIV / AIDS
Pediatric ARV $121 million
Second line ARV $162 million
PMTCT $75 million
Total $359 million
Malaria
ACT $209 million
LLINs $109 million
Total $318 million
Tuberculosis
First line TB $26 million
Pediatric TB $11 million
MDR-TB $71 million
Diagnostics $26 million
Total $136 million
Cross cutting issues
Transversal $52.5 million
Pre qualification medicines $47 million
Pre qualification diagnostics
$7.5 million
Total $107 million
UNITAID Projects around the world
HIV/AIDS: 49 countries
Malaria: 29 countries
Tuberculosis: 72 countries
With UNITAID funding, new treatments are put on the market where:
- Dosages are adapted to patients need – pediatric, second line
- Medicines can be taken in the form of tablets (fixed dose combinations)
- Products are heat stable: no refrigeration needed anymore
- No need for water to dilute medicines (problem of access to drinkable water in some countries).
- More quality products are available: 16 new prequalified medicines in 2008
More friendly-users medicines
Now (partnering with CHAI):Fixed dose combination
3 tablets a dayUS$ 60 per patient per year
Before: Single dose syrups
16 bottles of syrup monthlyUS$ 200 per patient per year
Better products at lower pricePediatric ARVs
Better products at lower price
Tuberculosis
• A rotating stockpile that treats 5800 patients a year
• New faster diagnostics that can detect MDR-TB in just two days (previous test took six weeks)
Global Laboratory Initiative
A unique partnership model